News
As a person affected by the loss of a loved one from cancer and a patient advocate, I’ve witnessed firsthand both the devastation of late-stage cancer diagnoses and the profound hope that early ...
Although one in two people will get cancer in their lifetime, and there are 385,000 cancer diagnoses each year in the UK, Powis believes that “we are at the cusp of a golden era in terms of the way we ...
A network dedicated to early phase trials of treatments for children with brain cancer will be phased out. A respected network of hospitals and cancer centers is halting enrollment in clinical trials ...
As we age, our cells replicate, and the DNA in these cells can acquire mistakes—or mutations—every time the sequence is copied. Most newly acquired mutations are harmless, but some can tip the balance ...
4d
Audacy on MSNPhilly cancer survivors and advocates rally for continued cancer research funding amid proposed federal cuts
Amid federal efforts to cut funding to cancer research, survivors and advocates rallied in the People’s Plaza at Independence Mall Tuesday for continued funding because of lives the research has saved ...
Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...
8d
Newspoint on MSNIndia on brink of health crisis, surge in diabetes, heart disease and cancer: Doctors sound alarm
New Delhi | India is on the cusp of a health crisis, with non-communicable diseases (NCDs) like diabetes, heart disease, and ...
Bayer has tapped Kumquat for a juicy opportunity, committing up to $1.3 billion to bag a KRAS G12D inhibitor that is on the cusp of the clinic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results